Primary cilia organize Hedgehog signaling and shape embryonic development, and their dysregulation is the unifying cause of ciliopathies. We conducted a functional genomic screen for Hedgehog signaling by engineering antibiotic-based selection of Hedgehog-responsive cells and applying genome-wide CRISPR-mediated gene disruption. The screen can robustly identify factors required for ciliary signaling with few false positives or false negatives. Characterization of hit genes uncovered novel components of several ciliary structures, including a protein complex that contains δ -tubulin and ε -tubulin and is required for centriole maintenance. The screen also provides an unbiased tool for classifying ciliopathies and showed that many congenital heart disorders are caused by loss of ciliary signaling. Collectively, our study enables a systematic analysis of ciliary function and of ciliopathies, and also defines a versatile platform for dissecting signaling pathways through CRISPR-based screening.
T he primary cilium is a surface-exposed microtubule-based compartment that serves as an organizing center for diverse signaling pathways [1] [2] [3] . Mutations affecting cilia cause ciliopathies, a group of developmental disorders including Joubert syndrome, Meckel syndrome (MKS), nephronophthisis (NPHP), and Bardet-Biedl Syndrome. The defining symptoms of ciliopathies include skeletal malformations, mental retardation, sensory defects, obesity, and kidney cysts, and are thought to arise from misregulation of ciliary signaling pathways. Advances in human genetics have led to the identification of more than 90 ciliopathy-associated genes 4 . However, the molecular basis for many ciliopathy cases remains undiagnosed 5 , and critical aspects of cilium assembly and function remain poorly understood.
A leading paradigm for ciliary signaling is the vertebrate Hedgehog (Hh) pathway, which plays key roles in embryonic development and in cancers such as medulloblastoma and basal cell carcinoma 6, 7 . Primary cilia are required for Hh-signaling output 3 , and all core components of the Hh-signaling machinery-from the receptor PTCH1 to the GLI transcriptional effectors-dynamically localize to cilia during signal transduction.
Efforts to systematically identify genes needed for cilium assembly or Hh signaling have been reported, but those studies have relied on arrayed short interfering RNA (siRNA) libraries and hence exhibit the high rates of false positives and false negatives characteristic of such screens [8] [9] [10] [11] . Recently, genome-wide screening using CRISPR-Cas9 for gene disruption has emerged as a powerful tool for functional genomics [12] [13] [14] [15] . However, the pooled screening format used in those studies requires a means to select for/against, or otherwise isolate, cells exhibiting the desired phenotype, a requirement that has limited the scope of biological applications amenable to this approach. Indeed, most studies to date have searched for genes that either intrinsically affect cell growth or affect sensitivity to applied perturbations [16] [17] [18] [19] [20] [21] [22] [23] .
Here, we engineered a Hh-pathway-sensitive reporter to enable an antibiotic-based selection platform. Combining this reporter with a single guide RNA (sgRNA) lentiviral library targeting the mouse genome, we conducted a CRISPR-based screen that systematically identified ciliary components, Hh-signaling machinery, and ciliopathy genes with few false positives or false negatives. We further show that previously uncharacterized hits encode new components of cilia and centrioles and also include novel ciliopathy genes.
Results

Development of a Hh-pathway reporter for pooled screening.
Pooled functional screening requires the ability to enrich or deplete mutants that exhibit a desired phenotype. Because ciliary signaling is not intrinsically linked to such a selectable phenotype, we engineered a reporter that converts Hh signaling into antibiotic resistance ( Fig. 1a,b ). This transcriptional reporter was introduced into mouse NIH-3T3 fibroblasts, a cell line widely used to study Hh signaling and cilium biology 24 , and these cells were then modified to express Cas9-BFP (and are denoted 3T3-[Shh-BlastR;Cas9] cells).
To validate our reporter cell line, we virally introduced sgRNAs targeting regulators of the Hh pathway (Supplementary Table 1 ). The transmembrane receptor SMO and intraflagellar transport (IFT) complex subunit IFT88 are required for Hh signaling, whereas SUFU and GLI3 restrain Hh-pathway activity (Fig. 1c, left) . As expected, sgRNAs targeting Smo or Ift88 severely decreased Sonic Hedgehog N-terminal domain (ShhN)-induced blasticidin resistance, whereas deleting Gli3 potentiated blasticidin resistance, and targeting Sufu led Articles NaTuRe GeNeTICS to ligand-independent blasticidin resistance ( Fig. 1c, right) . These effects on blasticidin resistance were paralleled by concordant changes in endogenous-pathway outputs, including GLI1 expression and changes in GLI3 processing ( Supplementary Fig. 1a ). Additionally, western blotting confirmed a loss of target-protein expression for Gli3, Ift88, and Sufu sgRNAs ( Supplementary Fig. 1a,b) .
We next tested the suitability of our reporter cells for pooled screening, which involves quantifying sgRNAs in blasticidinselected and unselected cell pools to identify sgRNAs that confer a selective advantage or disadvantage (Fig. 1d ). We mimicked screening conditions by mixing GFP-marked cells expressing a Smo sgRNA with mCherry-marked cells expressing a portion of 
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our genome-wide sgRNA library. Flow cytometry showed that the fraction of Smo sgRNA-transduced cells decreased by > 12-fold and by > 50-fold after one and two rounds of signaling and selection, respectively, thus indicating that our strategy is suitable for pooled screening (Fig. 1e,f ).
Genome-wide screening. We conducted our genome-wide screen by using a newly developed mouse sgRNA library 25 . Key features of this library are the use of ten sgRNAs per gene and the inclusion of > 10,000 negative-control sgRNAs that are either nontargeting or that target 'safe' sites with no predicted functional role ( Supplementary  Fig. 2a ). We lentivirally transduced 3T3-[Shh-BlastR;Cas9] cells with this library at a low multiplicity of infection and maintained sufficient cell numbers to ensure ~1,000× coverage of the library. Cells were next exposed to ShhN for 24 h to fully stimulate Hh signaling, split into separate blastidicin-selected and unselected pools, and then subjected to a second cycle of signaling and selection before sgRNA quantification by deep sequencing (Fig. 1d ). Genes affecting ciliary signaling were identified by comparing sgRNAs in the blastidicin-selected versus unselected cell pools, whereas genes affecting proliferation were identified by comparing the plasmid sgRNA library to the sgRNA population after 15 d of growth in the absence of blasticidin. For statistical analysis, a maximum-likelihood method termed casTLE 26 was used to determine a P value for each gene on the basis of the changes in sgRNA abundance. In addition, the casTLE method estimates the apparent strength of the phenotype (effect size) caused by knockout of a given gene.
Assessment of screen performance. We first assessed our ability to detect genes affecting growth. This readout was independent of our reporter-based selection strategy and enabled comparisons to other proliferation-based screens. Using reference positive and negative essential gene sets 27 , we found that our screen identified > 90% of essential genes with a 5% false discovery rate (FDR) ( Supplementary  Fig. 2b and Supplementary Tables 2 and 3 ). This performance validated the design of our sgRNA library and is comparable to that seen with other recently described libraries 18, 20 . We next evaluated the ability of our screen to identify genes known to participate in ciliary Hh signaling. Initial inspection of screen results for Smo, Ift88, Gli1, Gli3, and Sufu identified several sgRNAs targeting each gene that were depleted or enriched as expected after blasticidin selection ( Fig. 2a ). Virtually all known Hh-signaling components were among the top hits, including the positive regulators Smo, Grk2, Kif7, Prkar1a, Gli1, and Gli2 and the negative regulators Ptch1, Adcy6, Gsk3b, Sufu, and Gli3 ( Fig. 2b and Supplementary Table 4 ). Our screen also recovered hits that encompassed nearly all functional and structural elements of cilia, thus highlighting the diverse features of cilia needed for signaling ( Fig. 2c ). For example, several hits encoded components of the basal body, which nucleates the cilium; the transition fibers, which anchor the basal body to the cell surface; the transition zone, which gates protein entry into the cilium; the motors that mediate intraciliary transport; and the IFT complexes, which traffic ciliary cargos ( Fig. 2c and Supplementary Table 4 ). We observed no apparent correlation between growth and signaling phenotypes, thus indicating that our antibiotic selection strategy was not biased by general effects on proliferation ( Supplementary Fig. 2c ).
In total, we obtained 472 hits at a 10% FDR and 969 hits at a 20% FDR, and 92% of these hits led to decreased rather than increased signaling (Fig. 2b ). This asymmetry indicates that, under the saturating level of ShhN used here, many genes are required to sustain high-level signaling, whereas fewer genes act to restrain pathway output. Gene ontology (GO)-term analysis with the Database for Annotation, Visualization and Integrated Discovery (DAVID) 28 showed that the top 472 hit genes were enriched in expected functional categories (for example, cilium morphogenesis, with P = 9.6 × 10 −61 , and the Smoothened signaling pathway, with P < 3.6 × 10 −32 ) as well as some novel categories, thereby indicating new avenues for future investigation ( Fig. 2d and Supplementary  Table 5 ). In some cases, corroborating reports supported these new connections: mouse mutants for two hit genes that enable diphthamide modification have been found to exhibit Hh-pathwayrelated phenotypes such as polydactyly 29, 30 , and DPH1 mutations likewise cause a syndrome with ciliopathy-like features 31 .
We next sought to use reference sets of expected hit and nonhit genes to quantitatively assess screen performance. We curated a set of ciliogenesis reference genes 8 to generate a list of 130 expected hits; for expected nonhits, we used 1,386 olfactory-receptor and vomeronasal-receptor genes (Supplementary Table 3 ). We then calculated precision-recall and receiver operating characteristic (ROC) curves ( Fig. 3a ) from the P values generated by casTLE. Both performance metrics showed a high area under the curve (0.802 for precision recall, 0.892 for ROC), thus demonstrating that our screen detects hits with high sensitivity and precision ( Fig. 3a) .
Using a second means of evaluation, we compared the ability of our screen and of three related screens to detect expected hit genes. These studies used arrayed, siRNA-based screening to study either Hh signaling, by using a luciferase reporter 10 , or ciliogenesis, by using microscopy-based measures of ciliary markers 8, 9 . Although there were notable differences among the screens (for example, Roosing et al. incorporated gene expression data to score hits 8 ), they each defined a number of hit genes similar to that defined by our screen. Overall, we detected most expected hits across functional categories ranging from Hh-pathway components to ciliopathy genes. Furthermore, even though our screen was focused on Hh signaling, we detected a greater fraction of ciliary hits than did the ciliogenesis screens across categories including IFT subunits, ciliary motors, and nearly all classes of ciliopathy genes (Fig. 3b ,c, Supplementary Fig. 3a and Supplementary Table 4 ). Indeed, among the 88 genes encompassed by the categories shown in Fig. 3b (except for NPHP-specific genes; described below), we detected 65 as hits, thus indicating that our screen approached saturation ( Fig. 3c ). Interestingly, few hits were found for genes mutated exclusively in NPHP, thereby raising the possibility that the pathophysiology of NPHP may be distinct from that of other ciliopathies (Supplementary Note).
In a final assessment of our screening platform, we evaluated reproducibility across replicate screens. We observed high concordance among hits for the 95 genes measured in two different batches of the screen, such that 50 of 54 screen hits also scored as hits in the second batch ( Supplementary Fig. 3b ). Similarly, strong overlap in hits was found for 263 genes that were screened in parallel using two similar but distinct activators of Hh signaling: PTCH1 ligand (ShhN) and SMO agonist (SAG) ( Supplementary Fig. 3c ). This reproducibility made it possible to pinpoint genes acting at specific steps in Hh signal transduction. For example, Gas1 was a hit in the ShhN screen but not in the SAG screen, a result in agreement with GAS1's known function as a Shh co-receptor 32, 33 .
Identification of new ciliary components.
To further establish the value of our screen, we next set out to characterize six previously unstudied hit genes. We first focused on Fam92a and Ttc23 because their gene products contain domains associated with membrane trafficking. For Fam92a, we generated mutant cell pools by using individually cloned sgRNAs, then confirmed by sequencing that most cells contained likely null alleles 34 . Indeed, a high rate of mutagenesis was observed for all genes characterized here and below ( Supplementary Fig. 4a ). Fam92a disruption caused a strong defect in inducible blasticidin resistance ( Supplementary Fig. 4b ). This defect was also seen for induction of luciferase from a GLI-bindingsite reporter and was rescued by sgRNA-resistant Fam92a (Fig. 4a ), thus indicating that the phenotype is specific and independent of Articles NaTuRe GeNeTICS the blasticidin-based readout. Notably, ciliogenesis was severely decreased in Fam92a-knockout cell pools ( Fig. 4b ). To gain further insight into Fam92a function, we identified FAM92A-associated proteins from cells expressing FAM92A-LAP (S-tag-HRV3C-GFP localization and affinity-purification tag). The FAM92A-LAP purification specifically recovered CBY1 and DZIP1L, which are components of the transition zone [35] [36] [37] (Fig. 4c and Supplementary Table 6 ). In agreement with this finding, we detected FAM92A localization at the transition zone by using a validated antibody ( Supplementary  Fig. 4c,d ) and the FAM92A-LAP cell line ( Fig. 4d ). While this work was in progress, another group independently established FAM92A as a transition-zone protein that interacts with CBY1 and promotes ciliogenesis 38 .
To characterize the TPR-domain-containing protein TTC23, we identified TTC23-interacting proteins through affinity purification and mass spectrometry. Notably, the most prominent TTC23associated proteins were IQCE and EFCAB7, which localize to a proximal region of the cilium known as the Ellis-van Creveld (EvC) zone 39, 40 (Fig. 4e and Supplementary Table 6 ). Although the four known EvC-zone proteins are dispensable for cilium assembly, they TRAF3IP1  IFT80  IFT81  IFT88  IFT172   HSPB11   IFT27   CLUAP1  IFT57   TTC26   IFT52   IFT20   TTC30B   IFT74   IFT46   IFT-B   WDR19  WDR35  TTC21B  IFT122  IFT140  TULP3  IFT43 IFT-A 
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Overview of genome-wide-screen results. a, Scatter plot showing log 2 of normalized sgRNA counts in selected versus unselected cell pools, with sgRNAs targeting select genes highlighted. b, Volcano plot of casTLE P values versus effect sizes for all genes (after filtering; Methods), with select Hh-pathway components highlighted. Green area indicates a P-value cutoff corresponding to 10% FDR; combined green and yellow areas indicate 20% FDR, and the number of genes in each area is indicated (n). c, Schematic illustration of a primary cilium, with known structural features and select protein products of hit genes shown. Proteins shown are grouped by protein-complex membership or localization, and select newly identified hits are in bold and italics. d, For the indicated categories, proteins encoded by the hit genes identified are listed in order of statistical confidence. In addition to select GO terms enriched among screen hits, the top 100 hits not otherwise listed in a-c are shown.
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are all important for Hh signaling. Furthermore, mutations that affect the EvC-zone proteins EVC and EVC2 cause the ciliopathy Ellis-van Creveld syndrome [39] [40] [41] . In agreement with TTC23 being a new EvC-zone component, TTC23-LAP colocalized with EVC and IQCE at the EvC zone ( Fig. 4f and Supplementary Fig. 4e ). Although Ttc23 knockout had no effect on cilium assembly, mutant cells, compared with control cells, exhibited lower blasticidin resistance and less localization of IQCE and EVC to the EvC zone ( Fig. 4g and Supplementary Fig. 4b ,f-h). Similarly, Iqce RNA interference led to decreased localization of TTC23-LAP to the EvC zone ( Fig. 4h ). Together these results establish TTC23 as a novel EvC-zone component that participates in Hh signaling.
Identification of novel disease genes. Because most ciliopathy genes
were hits in the screen, we asked whether uncharacterized hit genes might be mutated in ciliopathies of previously unknown etiology.
We first examined Txndc15, which encodes a thioredoxin-domaincontaining transmembrane protein. A previous analysis of patients with MKS identified a family with a TXNDC15 mutation; however, a coincident EXOC4 variant was favored as the causative mutation 42 . We analyzed Txndc15-knockout cells by using luciferase reporter assays and found a clear defect in Hh signaling. Furthermore, wildtype Txndc15 rescued this defect, whereas the mutant allele found in people with MKS behaved like a null allele ( Fig. 5a ). We also found that cilia in Txndc15-knockout cells, as compared with control cells, exhibited greater variability in length and lower levels of the ciliary GTPase ARL13B ( Fig. 5b and Supplementary Fig. 5a,b ). Thus, TXNDC15 is likely to be a novel MKS gene. In agreement with our findings, a recent follow-up study has identified TXNDC15 mutations in additional families with MKS and has characterized ciliary defects resulting from TXNDC15 disruption 43 .
Our observation of Armc9 as a screen hit raises the possibility that it may also be a ciliopathy gene. Recently, Kar et al. reported that individuals with a homozygous mutation in ARMC9 exhibit mental retardation, polydactyly, and ptosis, but a diagnosis of Bardet-Biedl syndrome was disfavored 44, 45 . We found that cilia from Armc9-mutant cells were short and exhibited lower levels of acetylated and polyglutamylated tubulin than did control cells ( Fig. 5c and Supplementary Fig. 5c ). Furthermore, triple-FLAG-tagged (3× FLAG) ARMC9 localized to the proximal region in cilia when it was stably expressed in IMCD3 or NIH-3T3 cells (Fig. 5d ,e and Supplementary Fig. 5d ). Notably, stimulation of Hh signaling in IMCD3 cells led to redistribution of ARMC9 toward the ciliary tip within 6 h, then a gradual return to its original proximal location, thus suggesting that ARMC9 might become ectocytosed from the cilium tip at later time points 46, 47 (Fig. 5d,e ). This change in localization was due to Hh signaling, because it was blocked by the SMO inhibitor vismodegib ( Supplementary Fig. 5e ). Furthermore, Armc9-mutant NIH-3T3 cells, compared with control cells, exhibited less ciliary accumulation of GLI2 and GLI3 (but not SMO) after pathway activation, thus suggesting that ARMC9 participates in the trafficking and/or retention of GLI proteins at the ciliary tip ( Fig. 5f and Supplementary Fig. 5f -h). Collectively, these findings demonstrate that ARMC9 is a ciliary signaling factor and suggest that ARMC9 is a novel ciliopathy gene. Indeed, a recent study has confirmed that ARMC9 is mutated in Joubert syndrome and has reported that loss of the zebrafish ortholog disrupts cilium assembly and function 48 . That study has further demonstrated that ARMC9 localizes to centrioles in RPE cells, whereas we found that ARMC9-FLAG localized to cilia (Fig. 5d ,e and Supplementary Fig. 5d ) and was present in the ciliary proteome (D. Mick and M.V.N., unpublished data). Although the basis for these differing observations warrants further investigation, these data together show an important role for ARMC9 in ciliary signaling.
Our evidence that syndromes based on ARMC9 (and DPH1) probably represent unrecognized ciliopathies led us to ask whether our screen might help classify other genetic disorders as ciliopathies. In support of this possibility, CWC27, which encodes a peptidylprolyl isomerase, and INTS1 and INTS8, which encode subunits of the Integrator, are orthologs of screen hits for which patient mutations have recently been described 49 . Some canonical ciliopathy symptoms are present in these patients, and thus these disorders may stem from altered ciliary signaling (Supplementary Note).
These cases of individual disorders that can now be classified as likely ciliopathies led us to ask whether systematic efforts to map disease genes might show broader commonalities with our screen hits. We found that human orthologs of the screen hits Ankrd11, Cdk13, Chd4, Foxp1, Kmt2d, and Prkd1 were all identified in an exome-sequencing study of patients with congenital heart defects (CHD) 50, 51 . The significant overlap in these two unbiased datasets (P = 6.11 × 10 −4 ) indicates that defective ciliary signaling may be a prevalent cause of CHDs. Moreover, mutations in these genes 
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NaTuRe GeNeTICS appear to cause bona fide ciliopathies, because affected patients also exhibit ciliopathy symptoms including craniofacial abnormalities and developmental delay (ANKRD11, CDK13, CHD4, FOXP1, KMT2D, and PRKD1), dysgenesis of the corpus callosum (CDK13), polydactyly (CHD4), obesity (ANKRD11), and craniofacial malformations (ANKRD11 and KMT2D) 4,50,52 (Fig. 5g) .
A new protein complex for centriole stability. Because our screen hits include genes encoding the centriolar proteins CEP19, CEP44, CEP120, and CEP295 (refs [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] ), we considered whether other hits might also have centriolar functions. Indeed, the protein encoded by uncharacterized hit 1600002H07Rik (human C16orf59; official symbol TEDC2) localized to centrioles in IMCD3 cells (Fig. 6a ). We performed affinity purifications and found that 1600002H07Rik-LAP copurified with the uncharacterized protein 4930427A07Rik (human C14orf80) and the distant α /β -tubulin relatives ε -tubulin (TUBE1) and δ -tubulin (TUBD1) (Fig. 6b ). All four of the genes encoding these proteins were hits in our screen, and ε -tubulin and δ -tubulin have previously been linked to centriole assembly and maintenance [63] [64] [65] [66] [67] . We have therefore renamed 4930427A07Rik (C14orf80) and 1600002H07Rik (C16orf59) as Tedc1 and Tedc2, respectively, because of their association with a tubulin epsilon and delta complex.
Our mass spectrometry analysis of TEDC2-associated proteins showed approximately stoichiometric amounts of TEDC1, TEDC2, ε -tubulin, and δ -tubulin, as seen by comparison of the normalized spectral abundance factors ( Fig. 6b and Supplementary Table 6 ). We also recovered lower amounts of α /β -tubulin and CENPJ, a centriolar regulator of microtubule dynamics [68] [69] [70] . We confirmed copurification of TUBD1 and TUBE1 with TEDC2 by western blotting, and we readily detected these proteins in our TEDC2-LAP purification but not in a control purification ( Supplementary Fig. 6a ). The interaction between TEDC1 and TEDC2 was also detected by cotransfection and coimmunoprecipitation, and moreover we found that TEDC1 and TEDC2 mutually stabilized each other's expression ( Fig. 6c and Supplementary Fig. 6b ). In further support of our data, two largescale proteomic datasets have also identified interactions among TED-complex proteins 71, 72 .
To functionally characterize Tedc1 and Tedc2, we examined mutant cell pools and found that they were almost completely devoid of centrioles, as assessed by staining with antibodies to centrin, ninein, polyglutamylated tubulin or γ -tubulin (Fig. 7a,c,d) . Mutant cells also lacked cilia ( Fig. 7a ) and had strong defects in Hh signaling ( Supplementary Fig. 6c,d) . Notably, centrioles and cilia were restored in Tedc1-mutant cells after introduction of sgRNAresistant TEDC1-3× FLAG ( Supplementary Fig. 6e,f) , which also localized to centrioles ( Supplementary Fig. 6g ).
We noted that Tedc1 and Tedc2 mutants exhibited a mild growth defect ( Supplementary Table 3 ), which is consistent with recent evidence that NIH-3T3 cells lacking centrioles proliferate at a reduced rate 73 . In contrast, in other cell types, a p53-dependent arrest prevents growth in the absence of centrioles. These observations prompted us to investigate whether the varying effects of Tedc1 or Tedc2 disruption on proliferation across different cell types could enable predictive identification of genes with similar function. We therefore examined a collection of CRISPR-based growth screens conducted in 33 different human cell lines and used hierarchical clustering to group genes on the basis of their cell-type-specific growth phenotypes 74 . This unbiased approach placed TEDC1, TEDC2, and TUBE1 in a single cluster ( Fig. 7b and Supplementary  Table 7 ), thus suggesting that they share highly similar functions. Although TUBD1 was not found in this cluster, this absence was probably due to ineffective targeting of TUBD1 by the sgRNA library used. Indeed, although other CRISPR screens have reported pronounced growth defects for TUBD1 mutants 18, 25 , ref. 74 did not.
To better understand the basis for centriole loss in Tedc1 and Tedc2 mutants, we examined cells at different stages of the cell cycle. Whereas mutant cells typically had zero or one centriole in interphase, nearly all mitotic cells had excess centrioles (more than four), a result suggestive of de novo centriole formation before mitotic entry (Fig. 7c,d and Supplementary Fig. 6h ). In contrast, cells exiting mitosis showed significantly fewer centrioles than did control cells (Fig. 7d ). Together, these observations suggest that Tedc1 and Tedc2 are dispensable for centriole biogenesis but are required for centriole stability, and newly generated centrioles are rapidly lost as cells exit mitosis. In further support of a shared function of TEDcomplex components, TUBE1-and TUBD1-deficient human cells have recently been shown to have a similar phenotype 75 .
Discussion
Here we presented a functional screening platform that pairs a pathway-specific selectable reporter with genome-wide CRISPR-based gene disruption. Applying these technologies to cilium-dependent Hh signaling, we obtained a comprehensive portrait of cilium biology that identified hit genes with high sensitivity and specificity. Several factors probably contributed to the quality of our screen, including the pooled screening format, the use of CRISPR for gene disruption, and a newly designed sgRNA library (Supplementary Note). Furthermore, our use of a selectable pathway reporter makes this technology applicable to virtually any process with a welldefined transcriptional response.
Our pooled CRISPR-based screening approach enabled us to generate a rich dataset that should be a valuable resource for dissecting ciliary signaling, defining ciliopathy genes, and discovering potential therapeutic targets in Hh-driven cancers. Although siRNA-based screens have contributed to understanding of cilia and Hh signaling, these datasets have drawbacks of false positives or false negatives that limit their utility. Roosing et al. 8 improved their ciliogenesis-screen results by using reference gene sets to help Supplementary Fig. 6b and Supplementary Fig. 8 .
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NaTuRe GeNeTICS classify hits and by integrating gene expression datasets with their microscopy-based screen data. Our approach achieved high performance without dependence on other data sources, which may not always be available, or on a priori definition of hits, which could bias discovery of new hit classes. Our screens are also highly reproducible, thereby enabling comparative screening approaches that *** a d WT Ctrl sgRNA Supplementary Fig. 6h . One of three representative experiments. d, Centrioles marked by centrin3 and γ -tubulin were counted in cells at the indicated cell-cycle stages. Statistically significant differences in centriole counts are shown for select conditions (*P < 1 × 10 −6 ; **P < 1 × 10 −10 ; ***P < 1 × 10 −60 , determined by two-sided Fisher's exact test). Numbers of cells are shown in parentheses.
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should be instrumental in uncovering novel factors acting at specific steps in Hh signaling. Modifications to our screening strategy, such as performing screens in other cell lines or in unstimulated (or weakly stimulated) cells, may better replicate certain in vivo signaling modalities and may have improved sensitivity for identifying negative regulators of Hh signaling.
The value of our screen was demonstrated by the discovery of new genes that participate in ciliary signaling and new candidate ciliopathy genes. Although the precise roles of FAM92A at the transition zone and TTC23 at the EvC zone will require further study, our screen demonstrates that new components remain to be identified, even for well-studied ciliary structures. Similarly, our analyses of TXNDC15 , ARMC9, CWC27, DPH1, INTS6, INTS10, ANKRD11,  CDK13, CHD4, FOXP1, PRKD1 , and KTM2D illustrated that screen hits can help to identify a ciliopathy-causing gene from among a short list of variants, as is frequently the case in studies involving small pedigrees, and to classify new genetic syndromes as disorders of ciliary signaling. With the exception of TXNDC15, all of the aforementioned genes had been previously linked to disease without a potential role for cilia described (for example, KMT2D and Kabuki syndrome, MIM 147920; ANKRD11 and KBG syndrome, MIM 148050; and DPH1 and Loucks-Innes syndrome, MIM 616901). Among the syndromes caused by mutations in these genes, it is striking that the most prevalent feature was CHD. Our screen thus provides unbiased evidence that several CHD cases are ciliopathies, building upon similar connections observed in mice 76 and providing motivation for future investigations by human geneticists and developmental biologists.
Notably, few of the ciliopathy genes primarily linked to kidney pathology were found as screen hits, thus suggesting that these renal diseases are mechanistically distinct (Supplementary Note). By capturing an unbiased picture of cilium-based signaling, our screen refines the classification of ciliopathies. More broadly, as genome sequencing reveals disease-associated variants at ever-growing rates, genome-wide functional studies such as that presented here should become a powerful resource to distinguish disease-causing mutations from innocuous variants 77 and to gain insight into underlying disease mechanisms.
Our screen identifies hit genes with diverse roles in cilium function, Hh signaling, and centriole biology. For hits Tedc1, Tedc2, Tubd1, and Tube1, we found that these genes ensure centriole stability by acting in concert, as evidenced by the association of their gene products in a stoichiometric complex. This finding identifies a new direct link between ε -tubulin and δ -tubulin and raises the possibility that they may form a heterodimer analogous to α /β -tubulin. In addition to the physical association of TED-complex components, deficiency in TED-complex-encoding genes produced a remarkably similar pattern of growth phenotypes across cell lines. Moreover, these genes exhibited a similar phylogenetic distribution (Supplementary Table 8 , Supplementary Fig. 7 and Supplementary Note). Together, these observations provide further evidence of a shared function and illustrate the precise functional predictions made possible by CRISPR-based growth profiling 18 .
Studies in Paramecium, Tetrahymena, Chlamydomonas reinhardtii, and, most recently, human cells have shown that disrupting δ -tubulin or ε -tubulin leads to loss of the C and/or B tubules of the centriolar triplet microtubules 64, 66, 67, 75 . We propose that the centrioles formed in Tedc1-and Tedc2-deficient cells similarly lack triplet microtubules, thus causing them to degenerate during mitotic exit at the time when pericentriolar material (PCM) is stripped from the centrosome. Because removal of the PCM causes centriolar instability in fly spermatocytes 78 , postmitotic PCM removal may also trigger centriole loss in Tedc1 and Tedc2 mutants. CENPJ may ensure centriole stability by acting in concert with the TED complex, because CENPJ was found in our TEDC2 purifications, and a mutation in Cenpj has been found to disrupt triplet microtubules in Drosophila spermatocytes 79 .
Because CENPJ is a microcephaly gene 80, 81 , TED-complex components are potential candidate genes for this neurodevelopmental disorder.
In summary, we developed a functional screening platform that provides a resource for investigating long-standing questions in Hh signaling and primary cilia biology. By further applying these tools, it may become possible to systematically define vulnerabilities in Hh-pathway-driven cancers, to identify modifiers of Hh-pathwayinhibiting chemotherapeutics, and to search for suppressors of ciliopathies that may inform treatment. Integrating this functional genomic approach with complementary insights from proteomics and human genetics promises a rich tool kit for understanding ciliary signaling in health and disease.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41588-018-0054-7.
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Methods Experimental models and subject details. Cell lines and cell culture. NIH-3T3 and HEK293T cells were grown in high-glucose, pyruvate-supplemented DMEM (Gibco) with 10% fetal bovine serum (FBS), 2 mM glutamine, 10 U/ml penicillin, and 10 μ g/ml streptomycin (Gemini Bio-Products). NIH-3T3 FlpIn cells (gift from R. Rohatgi) were grown in the same medium supplemented with nonessential amino acids (Gibco). Light-II NIH-3T3 cells 24 were grown in the same medium except with 10% bovine calf serum (ATCC), and IMCD3 cells were grown in DMEM/F12 medium (Gibco) with FBS, glutamine, penicillin, and streptomycin additives. Serum starvation was done with medium with 0.5% FBS for NIH-3T3 cells, 0.5% calf serum for Light-II NIH-3T3 cells, and 0.2% FBS for IMCD3 cells. IMCD3 FlpIn cells were provided by P. Jackson. NIH-3T3 cells were obtained from ATCC. HEK239T-EcR-ShhN cells were provided by P. Beachy. Cells were confirmed to be mycoplasma free with the MycoAlert system (Lonza).
Method details. DNA cloning. Individual sgRNAs were cloned by ligating annealed oligonucleotides into pMCB306 or pMCB320 digested with BstXI and Bpu1102I (Fermentas FastDigest enzymes, Thermo Fisher). Ligated products were transformed into Mach1-T1 competent cells (Thermo Fisher), and recovered plasmids were verified by sequencing.
Cilia-focused sgRNA libraries were cloned from oligonucleotide pools (Agilent) as previously described 25 . Briefly, oligonucleotides were amplified with primer sequences common to each sublibrary, digested with BstXI and Bpu1102I, ligated into pMCB320, and transformed into Endura competent cells (Lucigen). DNA was isolated with a Plasmid Plus Giga kit (Qiagen).
Individual cDNAs were amplified from mouse cDNA or commercially available sources (Dharmacon) and cloned into Gateway Entry vectors via BP-clonasemediated recombination (Thermo Fisher) or with isothermal assembly. Mutations to introduce resistance to sgRNA-directed cleavage were introduced by isothermal assembly. Plasmids for expression of tagged genes of interest were generated from Entry vectors through LR-clonase-mediated recombination (Thermo Fisher) into Destination vectors encoding C-terminal LAP, 3× FLAG, or 6× Myc tags.
The plasmid pHR-Pgk-Cas9-BFP was cloned through digestion of pHR-SFFV-Cas9-BFP 16 and replacement of the SFFV promoter with the Pgk promoter amplified from pEFB/FRT-pCrys-AP Gpr161 NG3 -NsiI-pPgk-BirA-ER 46 . The plasmid pGL-8× Gli-Bsd-T2A-GFP-Hyg was generated in the pGL4.29-[luc2P/CRE/Hygro] vector (Promega) through replacement of the CRE response element with 8× Gli binding sites amplified from pGL3-8× Gli-Luc (P. Beachy) and of Luc2P with Bsd-T2A-GFP amplified from pEF5B-FRT-DEST-LAP 82 .
Virus production and cell transduction. VSVG-pseudotyped lentiviral particles were produced by cotransfection of HEK293T cells with a lentiviral vector and appropriate packaging plasmids (pMD2.G, pRSV-Rev, and pMDLg/RRE for sgRNAs expressed in pMCB320 or pMCB306; pCMV-Δ R-8.91 and pCMV-VSVG for Pgk-Cas9-BFP). After transfection with polyethyleneimine (linear, MW ~25,000, Polysciences), virus-containing supernatant was collected 24 h later and filtered through a 0.45-μ m cellulose acetate filter. For sgRNA libraries, a second harvest of viral medium was performed 24 h after the initial harvest. For Cas9-containing virus, lentiviral particles were concentrated 20-fold with Lenti-X Concentrator (Clontech).
Cells were transduced by addition of viral supernatants diluted to an appropriate titer in growth medium containing 4 μ g/ml polybrene (Sigma Aldrich). After a 24-h incubation at 37 °C, virus-containing medium was removed; after an additional 24 h, cells were passaged and, when appropriate, selection for transduced cells was commenced by addition of 2.0 μ g/ml puromycin (Invivogen). Multiplicity of infection was determined by flow cytometry.
ShhN production and titering. ShhN-containing conditioned medium was produced in HEK239T-EcR-ShhN cells. Cells were grown to 80% confluence, the medium was changed to DMEM with 2% FBS, and conditioned medium was collected after 48 h and filtered through a 0.22-μ m filter (EMD Millipore). The titer of ShhN was determined with NIH-3T3 Light-II reporter cells ('Luciferase reporter assays' section), and a concentration approximately twofold greater than the minimum dilution needed for full induction was used for further experiments (typically 1:12.5). Generation of stable cell lines. The 3T3-[Shh-BlastR;Cas9] reporter cell line was generated by transfection of NIH-3T3 cells with pGL-8× Gli-Bsd-T2A-GFP-Hyg, using Lipofectamine 2000 (Thermo Fisher). After selection for hygromycinresistant cells, clonal isolates were obtained by limiting dilution and tested for SAG-induced blastidicin resistance. Pgk-Cas9-BFP was introduced lentivirally, and this was followed by three rounds of FACS sorting for high-level BFP expression.
Stable cell lines for affinity purification and localization studies were generated with the FlpIn system (Life Technologies) with IMCD3 FlpIn or NIH-3T3 FlpIn cells. Plasmids encoding genes of interest in the pEF5B/FRT-DEST-LAP (or 3× FLAG) vector were transfected into FlpIn cells together with pOG44 Flp recombinase (Life Technologies) with X-tremegene 9 (Roche). Recombined cell pools were obtained after selection with blasticidin (Sigma Aldrich).
Rescue of Tedc1-mutant cells was performed by lentiviral transduction with a construct expressing sgRNA-resistant mouse TEDC1-3× Flag-T2A-GFP. This construct was expressed from the Pgk promoter, and cells were analyzed 7-14 d after transduction.
Blasticidin reporter assays. 3T3-[Shh-BlastR;Cas9] cells were seeded for signaling and grown to near confluence. Growth medium was replaced with serumstarvation medium with or without pathway agonist (ShhN conditioned medium or 250 nM SAG, synthesized as previously described 83, 84 ). After 24 h, cells were passaged at an ~1:6 dilution into medium with 10% FBS, and 5 h later were subjected to selection with blasticidin (blasticidin S hydrochloride, Sigma Aldrich) for 4 d. Relative viability was determined with the CellTiter-Blue assay (Promega) with a SpectraMax Paradigm (Molecular Devices) or Infinite M1000 (Tecan) plate reader.
Genome-wide screening. Owing to the large number of cells required, we conducted the screen in four batches with subsets of the library containing ~45,000-70,000 sgRNAs 25 (Supplementary Fig. 2a ). For each batch, lentivirus was produced and titered as described above. 3T3-[Shh-BlastR;Cas9] cells were grown in 15-cm plates and transduced at a multiplicity of infection of ~0.3 in sufficient numbers such that there was a ~500:1 ratio of transduced cells to sgRNA library elements. Cells were selected with puromycin for 5 d, grown for 3 d without puromycin, and then plated for signaling, and a ~1,000:1 ratio of cells to sgRNAs was maintained during these and all subsequent steps. After cells reached confluence, signaling was initiated by addition of serum-starvation medium containing ShhN. After 24 h, cells were passaged, allowed to adhere, and then subjected to blasticidin selection for 4 d at 5 μ g/ml, a concentration that we found sufficient to achieve strong enrichment/ depletion of hits without causing sgRNA library bottlenecks due to excess cell death. After passaging cells to blasticidin-free medium, a 'T1' sample was harvested (1,000-fold more cells than sgRNAs), and the remaining cells were passaged once more before seeding for a second round of signaling and selection. The final 'T2' cell sample was collected after a 4-d blasticidin selection and one additional passage in the absence of blasticidin. Unselected control cells were also propagated through the entire experiment and harvested at equivalent time points.
Screens with the cilia/Hh pathway-focused library were conducted as above except that a variant blasticidin reporter cell line was used, in which Cas9-BFP was expressed with the shortened EF1α promoter. Because some Cas9-negative cells accumulated during the experiment, the final blasticidin-selected and unselected cells were FACS-sorted for BFP expression.
To process cell samples for sgRNA sequencing, genomic DNA was isolated with QiaAmp DNA Blood Maxi or QiaAmp DNA mini kits (Qiagen). Genomic DNA was then amplified with Herculase II polymerase (Agilent) as previously described 16 , first with outer primers to amplify the sgRNA cassette, then with inner primers to amplify a portion of the initial PCR product while introducing samplespecific barcodes and adapters for Illumina sequencing (Supplementary Table 9 ). Gel-purified PCR products were quantified with a Qubit 2.0 fluorometer with the dsDNA HS kit (Thermo Fisher) and pooled for sequencing. Deep sequencing was performed on a NextSeq 500 sequencer with high-output v2 kits (Illumina) to obtain an ~500-fold excess of reads to sgRNA library elements. Sequencing was performed with a custom primer to read the sgRNA protospacer (Supplementary Table 9 ).
Cas9-induced mutation analysis by sequencing. Genomic DNA from sgRNAtransduced cell pools was extracted with a QIAamp DNA Mini kit (Qiagen) and amplified with primers flanking the sgRNA target site ( Supplementary Table 1 ). Gel-purified PCR products were subjected to Sanger sequencing, and the resulting chromatograms were analyzed with tracking of indels by sequence decomposition (TIDE) 34 .
Luciferase reporter assays. Luciferase reporter assays were conducted with 3T3-[Shh-BlastR;Cas9] cells cotransfected with pGL3-8× Gli-Firefly-luciferase and pGL3-SV40-Renilla-luciferase. One day after plating, cells were transfected with Mirus TransIT-2020 (Mirus Bio) with luciferase plasmids and either control GFPencoding plasmid (pEF5B-FRT-GFP-FKBP) 85 or a plasmid encoding a gene of interest. Nearly confluent cells were switched to serum-starvation medium with or without pathway agonist 24 h later and were allowed to signal for 24-30 h. Alternatively, luciferase assays for titering ShhN-conditioned medium were performed with the NIH-3T3 Light-II cell line, which has stably integrated versions of GLI-driven firefly luciferase and constitutively expressed Renilla luciferase. After signaling, cells were lysed in lysis buffer (12.5 mM Tris, pH 7.4, 4% glycerol, 0.5% Triton X-100, 0.5 mg/ml BSA, 1 mM EGTA, and 1 mM DTT) and a dual-luciferase measurement was performed with a Modulus microplate luminometer (Turner Biosystems).
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Analysis of mass spectrometry data. MS/MS data were analyzed with both Preview and Byonic v2.10.5 (ProteinMetrics). All data were first analyzed in Preview to provide recalibration criteria if necessary and were then reformatted to MGF format before full analysis with Byonic. Data were searched at 12-p.p.m. mass tolerances for precursors, with 0.4-Da fragment mass tolerances assuming up to two missed cleavages and allowing for fully specific and ragged tryptic peptides. The database used was UniProt for Mus musculus, downloaded on 25 October 2016. These data were validated at a 1% FDR with typical reverse-decoy techniques 87 . The resulting identified peptide spectral matches and assigned proteins were then exported for further analysis with Matlab (MathWorks) to provide visualization and statistical characterization.
Analysis of CRISPR growth-screen datasets. Gene-level growth phenotype data 74 were downloaded from the Achilles website. Hierarchical clustering with uncentered correlation and average linkage settings was performed with Cluster 3.0 software 88 , and clustered data were visualized in Java Treeview 89 .
Phylogenetic analysis. Homologs for Tubd1 and Tube1 were either previously described 90 or identified with protein BLAST. Homologs for Tedc1 and Tedc2 were identified with iterative searches with PSI-BLAST 91 . To analyze sequence divergence, homolog sequences were first aligned with Clustal Omega 92 . Phylogenetic trees were generated via neighbor joining with distance correction with Simple Phylogeny 92 and visualized with Unrooted 93 .
Code availability. Software used for casTLE analysis can be found at http://bitbucket.org/dmorgens/castle/. Matlab scripts for quantification of cilium intensities and length are available upon request.
Life Sciences Reporting Summary. Further information on experimental design is available in the Life Sciences Reporting Summary.
Data availability. The data supporting the findings of this study are available within the paper and its Supplementary Information files, with the exception of raw Illumina sequencing data and sequencing-based analysis of CRISPR-induced mutations, which are available upon request.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed). n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
Software used for analysis of screen sequencing data includes Bowtie (ref. 87 ) and the casTLE algorithm (https://bitbucket.org/dmorgens/castle, also ref. 26 ). Custom Matlab scripts for cilia image analysis are available upon request.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
There are no restrictions on availability of materials.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
Antibody sources are in Supplementary Table 10 . FAM92A Ab was validated in Supplementary Fig. 4d . SUFU, GLI3, GLI1, and IFT88 antibodies were validated using WB analysis of KO cells (Supp. Fig. 1 and data not shown). Antibodies to TUBD1 and TUBE1 were validated by the Human Protein Atlas using Western blotting and protein arrays, and we detect a band of expected MW specifically in samples confirmed to contain the antigen by mass spectrometry. IQCE and EVC specificity were validated by RNAi in Fig. 4h and in refs. 39-40. CBY1 8-2 antibody was validated in PMID 21529289 and 25103236. SMO Ab was validated for immunofluorescence in PMID 21552265. GLI2 Ab was validated in KO cells in PMID 26193634. All other antibodies are extensively used in the field and have been used in dozens or more publications.
